ALTEA FARMACEUTICA
ALTEA FARMACEUTICA, a prominent player in the pharmaceutical industry, is headquartered in Colombia (CO) and operates extensively across Latin America. Founded in 2005, the company has established itself as a leader in the development and distribution of high-quality pharmaceutical products, particularly in the fields of oncology, cardiology, and infectious diseases. With a commitment to innovation, ALTEA FARMACEUTICA offers a diverse portfolio of medications that are distinguished by their efficacy and safety profiles. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market presence. Recognised for its dedication to improving patient outcomes, ALTEA FARMACEUTICA continues to strengthen its position in the competitive pharmaceutical landscape, making strides in research and development to meet the evolving needs of healthcare providers and patients alike.
DitchCarbon Score
How does ALTEA FARMACEUTICA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ALTEA FARMACEUTICA's score of 5 is lower than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ALTEA FARMACEUTICA's reported carbon emissions
In 2022, ALTEA FARMACEUTICA reported total carbon emissions of approximately 28,990 kg CO2e from Scope 1 and Scope 2 sources. This includes about 25,860 kg CO2e from direct emissions (Scope 1) and approximately 5,320 kg CO2e from indirect emissions associated with energy consumption (Scope 2, market-based). The company also reported about 3,130 kg CO2e from Scope 2 emissions based on location. Currently, ALTEA FARMACEUTICA has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. As such, their climate commitments remain unclear, and there are no documented pledges or targets under the Science Based Targets initiative (SBTi). In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction strategies, making it essential for ALTEA FARMACEUTICA to establish clear climate commitments to align with industry standards and expectations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | |
|---|---|
| Scope 1 | 25,860 |
| Scope 2 | 5,320 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ALTEA FARMACEUTICA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
